SAM
Senzar Asset Management Portfolio holdings
AUM
$34.7M
This Quarter Return
-17.71%
1 Year Return
+0.55%
3 Year Return
-0.75%
5 Year Return
–
10 Year Return
–
AUM
$504M
AUM Growth
+$504M
(-44%)
Cap. Flow
-$280M
Cap. Flow
% of AUM
-55.63%
Top 10 Holdings %
Top 10 Hldgs %
63.87%
Holding
48
New
7
Increased
17
Reduced
13
Closed
11
Top Buys
| 1 |
Amgen
AMGN
|
$40.4M |
| 2 |
Elevance Health
ELV
|
$28.5M |
| 3 |
SHPG
Shire pic
SHPG
|
$20.7M |
| 4 |
Labcorp
LH
|
$14.9M |
| 5 |
MNTA
Momenta Pharmaceuticals, Inc.
MNTA
|
$6.08M |
Top Sells
| 1 |
Bausch Health
BHC
|
$132M |
| 2 |
Viatris
VTRS
|
$42.5M |
| 3 |
Teva Pharmaceuticals
TEVA
|
$38.7M |
| 4 |
AET
Aetna Inc
AET
|
$37.7M |
| 5 |
STJ
St Jude Medical
STJ
|
$31.3M |
Sector Composition
| 1 | Healthcare | 88% |
| 2 | Financials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
NVRO
1
DELISTED
NEVRO CORP.
NVRO
| $83.5M | 16.57% |
1,483,730
-199,147
| -12% | -$11.2M |
|
|
2
Amgen
AMGN
$155B
| $40.4M | 8.02% |
+269,300
| New | +$40.4M |
|
|
AGN
3
DELISTED
Allergan plc
AGN
| $38.5M | 7.65% |
143,748
+19,248
| +15% | +$5.16M |
|
|
4
Teva Pharmaceuticals
TEVA
$21.1B
| $29.9M | 5.94% |
558,889
-722,300
| -56% | -$38.7M |
|
|
5
Elevance Health
ELV
$71.8B
| $28.5M | 5.65% |
+204,700
| New | +$28.5M |
|
|
AET
6
DELISTED
Aetna Inc
AET
| $22.5M | 4.46% |
200,000
-335,532
| -63% | -$37.7M |
|
|
TVTY
7
DELISTED
Tivity Health, Inc. Common Stock
TVTY
| $22.4M | 4.45% |
2,221,481
-303,563
| -12% | -$3.06M |
|
|
SHPG
8
DELISTED
Shire pic
SHPG
| $20.7M | 4.12% |
+120,700
| New | +$20.7M |
|
|
CNCE
9
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $20.1M | 3.99% |
1,471,693
+39,076
| +3% | +$534K |
|
10
Travere Therapeutics
TVTX
$1.56B
| $15.2M | 3.02% |
1,114,592
+55,710
| +5% | +$761K |
|
|
11
Labcorp
LH
$23.1B
| $14.9M | 2.95% |
+126,800
| New | +$14.9M |
|
12
Insmed
INSM
$28.8B
| $14M | 2.78% |
1,104,998
+415,891
| +60% | +$5.27M |
|
|
ALDR
13
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
| $12.6M | 2.5% |
513,570
-43,600
| -8% | -$1.07M |
|
14
Universal Health Services
UHS
$11.6B
| $11.2M | 2.22% |
89,500
-45,700
| -34% | -$5.7M |
|
|
MNTA
15
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $11.1M | 2.2% |
1,199,891
+657,800
| +121% | +$6.08M |
|
|
ITCI
16
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $10.6M | 2.11% |
382,924
+30,000
| +9% | +$834K |
|
|
FOMX
17
DELISTED
Foamix Pharmaceuticals Ltd. Ordinary Shares
FOMX
| $10.4M | 2.07% |
1,599,031
+101,600
| +7% | +$662K |
|
18
Enanta Pharmaceuticals
ENTA
$180M
| $9.95M | 1.98% |
338,851
+174,865
| +107% | +$5.14M |
|
|
ELOS
19
DELISTED
Syneron Medical Ltd
ELOS
| $9.27M | 1.84% |
1,267,982
-138,300
| -10% | -$1.01M |
|
20
Tandem Diabetes Care
TNDM
$845M
| $7.75M | 1.54% |
889,449
-40,600
| -4% | -$354K |
|
21
Select Medical
SEM
$1.61B
| $7.64M | 1.52% |
646,624
+154,624
| +31% | +$1.83M |
|
22
ANI Pharmaceuticals
ANIP
$2.03B
| $7.54M | 1.5% |
223,871
-229,981
| -51% | -$7.74M |
|
|
CORI
23
DELISTED
Corium International, Inc.
CORI
| $6.7M | 1.33% |
1,735,966
+414,487
| +31% | +$1.6M |
|
24
Rocket Pharmaceuticals
RCKT
$354M
| $5.53M | 1.1% |
747,900
+438,300
| +142% | +$3.24M |
|
|
DERM
25
DELISTED
Dermira, Inc.
DERM
| $5.45M | 1.08% |
263,300
+15,800
| +6% | +$327K |
|